Jump to main content
Jump to site search

Issue 5, 2014
Previous Article Next Article

Hydrogen sulfide donors in research and drug development

Author affiliations

Abstract

Hydrogen sulfide (H2S) has recently emerged as an important biological gasomediator as a result of numerous insightful studies. The use of H2S releasing compounds has attracted much attention as they can exert crucial effects on a wide range of cellular signaling processes. Some of these effects are potentially exploitable in terms of anti-inflammatory and anti-tumor effects, as well as precise ion-channel regulation, cardiovascular protection and oxidation resistance. Unfortunately, the potential therapeutic effects of H2S are controversial due to conflicting published results regarding its effects on cellular activities arising, perhaps in part, from the use of different H2S donors. Therefore it is essential to review the most commonly used H2S releasing compounds, some of which are currently in clinical trials along with their associated in vitro and/or in vivo biological effects.

Graphical abstract: Hydrogen sulfide donors in research and drug development

Back to tab navigation

Publication details

The article was received on 28 Nov 2013, accepted on 13 Feb 2014 and first published on 14 Feb 2014


Article type: Review Article
DOI: 10.1039/C3MD00362K
Author version available: Download Author version (PDF)
Citation: Med. Chem. Commun., 2014,5, 557-570
  •   Request permissions

    Hydrogen sulfide donors in research and drug development

    Z. J. Song, M. Y. Ng, Z. Lee, W. Dai, T. Hagen, P. K. Moore, D. Huang, L. Deng and C. Tan, Med. Chem. Commun., 2014, 5, 557
    DOI: 10.1039/C3MD00362K

Search articles by author

Spotlight

Advertisements